Interestingly, Van et al discovered that ablating RIPK1 in liver parenchymal cells did not cause spontaneous liver pathology, while combined deficiency of RIPK1 and RelA protein would lead to chronic liver disease and hepatocellular carcinoma [54]. Here, RIPK1 is linked to hepatocellular carcinoma.